GenovaGENOVA,Inc.9341東証プライムサービス業FY ending Mar 2026, consolidated, J-GAAP
About 63% of Genova's sales come from Medical platform business, with Smart clinic business and Other making up much of the rest.
Out of every ¥100 of sales, about ¥27 is left as operating profit.
Revenue changed +35.6% from the prior year, operating profit +64.4%.
Revenue +35.6% · profit +64.4%, calculated from disclosed figures.
Operating leverage: 1.81× (profit growth ÷ revenue growth)
FY ending Mar 2022 → FY ending Mar 2023
FY ending Mar 2022 → FY ending Mar 2023
For every ¥100 Genova sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
Revenue by business segment, and the profit each one keeps.
※ Segment figures include inter-segment sales and do not sum to the company total
EDINET (FSA Japan)
有価証券報告書-第21期(2025/04/01-2026/03/31)
EDINET (FSA Japan)
有価証券報告書-第20期(2024/04/01-2025/03/31)
EDINET (FSA Japan)
有価証券報告書-第19期(2023/04/01-2024/03/31)
EDINET (FSA Japan)
有価証券報告書-第18期(2022/04/01-2023/03/31)
Extracted from XBRL: 46 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.